AIN vs REGN · P/E 28, rev $1.23B vs P/E 14, rev $14.34B
Albany International Corporation (AIN) versus Regeneron Pharmaceuticals Inc (REGN) — a side-by-side from cached financials, not a winner call.
Albany International Corporation (AIN) is a textile manufacturing company listed on US.
Regeneron Pharmaceuticals Inc (REGN) is a biotechnology company listed on US.
Latest reported AIN revenue for 2024-12-31 was $1.23B. Net income was $88.1M. Revenue was up 7.2% from 2023-12-31 to 2024-12-31. AIN currently screens at market cap $2.10B and trailing P/E 27.9.
Latest reported REGN revenue for 2025-12-31 was $14.34B. Net income was $4.50B. Revenue was up 1.0% from 2024-12-31 to 2025-12-31. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
AIN currently screens at market cap $2.10B and trailing P/E 27.9. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
Not investment advice. Open the AIN and REGN stock pages for the full models.
Not investment advice.